127554-90-9Relevant articles and documents
EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS
-
Page/Page column 34; 35; 36, (2015/06/25)
Methods and compositions for the catalytic oxidation of pharmaceutically active compounds, and more particularly to ex vivo methods for predicting in vivo metabolism of pharmaceutically active compounds, including predicting in vivo interaction between two or more pharmaceutically active compounds.
Sex difference in pharmacokinetics of the novel sulfonylurea antidiabetic glimepiride in rats
Yamazaki,Tabata
, p. 1317 - 1321 (2007/10/02)
Glimepiride (Hoe 490, CAS 93479-97-1), a novel sulfonylurea antidiabetic agent, was studied for the cause of sex-related difference in the elimination clearance of the unchanged drug in rats. After intravenous and oral administration, the serum level of t